FindMyKOL
Clinical trialNCT07877883Enrolling, by, invitationObservational

Safety, Feasibility, and Acceptability of the MINERVA Voice Conversational Agent for Emergency Department History-Taking

SponsorBeth Israel Deaconess Medical CenterEnrollment250Artificial Intelligence (AI)History Taking
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study evaluates whether an artificial intelligence (AI) conversational agent called MINERVA (Medical Interface for Navigating the Emergency Room with Voice Assistance) can safely and feasibly gather medical histories from emergency department (ED) patients and produce accurate summaries. The main questions it aims to answer are: Can an AI conversational agent gather and summarize patient histories in the emergency department? Are the resulting summaries accurate? Do they capture essential clinical information? Can an AI agent overseeing these conversations independently identify red-flag symptoms that may need time-sensitive clinical interventions? Adult ED patients interact with MINERVA via either voice chat or typing on a keyboard. MINERVA asks them questions about their symptoms and generates a summary which the patients review for accuracy. MINERVA reviews the conversation for clinical red flags that suggest urgent evaluation is required. Participants fill out a survey providing feedback on their experience. The summary is not saved in the medical record and clinical care is not affected. Physician reviewers will evaluate the safety, accuracy, and clinical value of the MINERVA interview transcripts and summaries using standardized rubrics, including whether MINERVA was correct in identifying red-flag symptoms that may need time-sensitive clinical interventions.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Oct 2026
Primary completion
1 Jan 2027
Completion
1 Feb 2027
Last update posted
16 Oct 2026
Registered enrollment
250
Registry id
NCT07877883

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.